Unknown

Dataset Information

0

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1.


ABSTRACT:

SUBMITTER: Jacobson I 

PROVIDER: S-EPMC4806200 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Aim</h4>To evaluate daclatasvir vs telaprevir, each combined with peginterferon alfa-2a/ribavirin (pegIFN/RBV), in treatment-naive hepatitis C virus (HCV) genotype (GT) 1-infected patients.<h4>Methods</h4>In this phase 3, randomized, open-label, noninferiority study, 602 patients were randomly assigned (2:1) to daclatasvir vs telaprevir, stratified by IL28B rs12979860 host genotype (CC vs non-CC), cirrhosis status (compensated cirrhosis vs no cirrhosis), and HCV GT1 subtype (GT1a vs GT1b). P  ...[more]

Similar Datasets

| S-EPMC3910820 | biostudies-literature
| S-EPMC4929089 | biostudies-literature
| S-EPMC5066958 | biostudies-literature
| S-EPMC4990525 | biostudies-literature
| S-EPMC4023772 | biostudies-literature
| S-EPMC4606559 | biostudies-literature
| S-EPMC4805724 | biostudies-literature
| S-EPMC4318982 | biostudies-literature
| S-EPMC1860092 | biostudies-literature
| S-EPMC5411384 | biostudies-literature